Somatic mutations that disrupt the Nrf-2-Keap1 interaction to stabilize Nrf-2 and increase the constitutive transcription of Nrf-2 target genes were recently identified in tumor cells [50], [34], indicating enhanced ROS detoxification. Here, NFE2L2 is linked to neoplasm.